Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis

Han Chieh Lin, Yang Te Tsai, Fa Yauh Lee, Ting-Tsung Chang, Sun Sang Wang, Chii Shyan Lay, Shou Dong Lee, Kwang Juei Lo

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

We measured the haemodynamic changes following triglycyllysine vasopressin administration and after addition of nitroglycerin in twelve patients with portal hypertension due to hepatitis B-related cirrhosis. A bolus i.v. injection of triglycyllysine vasopressin at a dose of 2 mg reduced the hepatic venous pressure gradient from 18.5 ± 3.7 (mean ± S.D.) to 15.6 ±4.0 mmHg, p < 0.001. However, the cardiac index decreased from 4.8 ± 1.0 to 3.7 ± 0.81/min m2, p < 0.001; the heart rate decreased from 79 ± 15 to 71 ± 13, p < 0.01; the right atrial pressure increased from 3.2 ± 1.9 to 5.3 ± 2.3 mmHg, p < 0.001; the mean arterial pressure increased from 92 ± 13 to 103 ± 13 mmHg, p < 0.05; and the systemic vascular resistance rose from 939 ± 182 to 1367 ± 310 dyn/s cm-5, p < 0.001. Furthermore, both mean pulmonary arterial pressure and pulmonary capillary wedge pressure showed a significant increase following triglycyllysine vasopressin administration as compared with baseline values (p < 0.005). The addition of sublingual nitroglycerin at a dose of 0.6 mg returned all the systemic haemodynamic parameters to baseline levels. On the other hand, nitroglycerin administration caused no further change in the hepatic venous pressure gradient. We concluded that although triglycyllysine vasopressin significantly reduced portal pressure in patients with hepatitis B-related cirrhosis, it produced untoward systemic haemodynamic changes similar to those seen with vasopressin. The addition of nitroglycerin improved the detrimental systemic haemodynamic effects produced by triglycyllysine vasopressin without further reducing the hepatic venous pressure gradient.

Original languageEnglish
Pages (from-to)370-374
Number of pages5
JournalJournal of Hepatology
Volume10
Issue number3
DOIs
Publication statusPublished - 1990 Jan 1

Fingerprint

Nitroglycerin
Hepatitis B
Vasopressins
Fibrosis
Hemodynamics
Venous Pressure
Liver
Arterial Pressure
Portal Pressure
Pulmonary Wedge Pressure
Atrial Pressure
Portal Hypertension
Vascular Resistance
Heart Rate
Lung
Injections

All Science Journal Classification (ASJC) codes

  • Hepatology

Cite this

Lin, Han Chieh ; Tsai, Yang Te ; Lee, Fa Yauh ; Chang, Ting-Tsung ; Wang, Sun Sang ; Lay, Chii Shyan ; Lee, Shou Dong ; Lo, Kwang Juei. / Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis. In: Journal of Hepatology. 1990 ; Vol. 10, No. 3. pp. 370-374.
@article{f4daeb28e7be4c6387fa0e6a8cd3919f,
title = "Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis",
abstract = "We measured the haemodynamic changes following triglycyllysine vasopressin administration and after addition of nitroglycerin in twelve patients with portal hypertension due to hepatitis B-related cirrhosis. A bolus i.v. injection of triglycyllysine vasopressin at a dose of 2 mg reduced the hepatic venous pressure gradient from 18.5 ± 3.7 (mean ± S.D.) to 15.6 ±4.0 mmHg, p < 0.001. However, the cardiac index decreased from 4.8 ± 1.0 to 3.7 ± 0.81/min m2, p < 0.001; the heart rate decreased from 79 ± 15 to 71 ± 13, p < 0.01; the right atrial pressure increased from 3.2 ± 1.9 to 5.3 ± 2.3 mmHg, p < 0.001; the mean arterial pressure increased from 92 ± 13 to 103 ± 13 mmHg, p < 0.05; and the systemic vascular resistance rose from 939 ± 182 to 1367 ± 310 dyn/s cm-5, p < 0.001. Furthermore, both mean pulmonary arterial pressure and pulmonary capillary wedge pressure showed a significant increase following triglycyllysine vasopressin administration as compared with baseline values (p < 0.005). The addition of sublingual nitroglycerin at a dose of 0.6 mg returned all the systemic haemodynamic parameters to baseline levels. On the other hand, nitroglycerin administration caused no further change in the hepatic venous pressure gradient. We concluded that although triglycyllysine vasopressin significantly reduced portal pressure in patients with hepatitis B-related cirrhosis, it produced untoward systemic haemodynamic changes similar to those seen with vasopressin. The addition of nitroglycerin improved the detrimental systemic haemodynamic effects produced by triglycyllysine vasopressin without further reducing the hepatic venous pressure gradient.",
author = "Lin, {Han Chieh} and Tsai, {Yang Te} and Lee, {Fa Yauh} and Ting-Tsung Chang and Wang, {Sun Sang} and Lay, {Chii Shyan} and Lee, {Shou Dong} and Lo, {Kwang Juei}",
year = "1990",
month = "1",
day = "1",
doi = "10.1016/0168-8278(90)90149-L",
language = "English",
volume = "10",
pages = "370--374",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "3",

}

Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis. / Lin, Han Chieh; Tsai, Yang Te; Lee, Fa Yauh; Chang, Ting-Tsung; Wang, Sun Sang; Lay, Chii Shyan; Lee, Shou Dong; Lo, Kwang Juei.

In: Journal of Hepatology, Vol. 10, No. 3, 01.01.1990, p. 370-374.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis

AU - Lin, Han Chieh

AU - Tsai, Yang Te

AU - Lee, Fa Yauh

AU - Chang, Ting-Tsung

AU - Wang, Sun Sang

AU - Lay, Chii Shyan

AU - Lee, Shou Dong

AU - Lo, Kwang Juei

PY - 1990/1/1

Y1 - 1990/1/1

N2 - We measured the haemodynamic changes following triglycyllysine vasopressin administration and after addition of nitroglycerin in twelve patients with portal hypertension due to hepatitis B-related cirrhosis. A bolus i.v. injection of triglycyllysine vasopressin at a dose of 2 mg reduced the hepatic venous pressure gradient from 18.5 ± 3.7 (mean ± S.D.) to 15.6 ±4.0 mmHg, p < 0.001. However, the cardiac index decreased from 4.8 ± 1.0 to 3.7 ± 0.81/min m2, p < 0.001; the heart rate decreased from 79 ± 15 to 71 ± 13, p < 0.01; the right atrial pressure increased from 3.2 ± 1.9 to 5.3 ± 2.3 mmHg, p < 0.001; the mean arterial pressure increased from 92 ± 13 to 103 ± 13 mmHg, p < 0.05; and the systemic vascular resistance rose from 939 ± 182 to 1367 ± 310 dyn/s cm-5, p < 0.001. Furthermore, both mean pulmonary arterial pressure and pulmonary capillary wedge pressure showed a significant increase following triglycyllysine vasopressin administration as compared with baseline values (p < 0.005). The addition of sublingual nitroglycerin at a dose of 0.6 mg returned all the systemic haemodynamic parameters to baseline levels. On the other hand, nitroglycerin administration caused no further change in the hepatic venous pressure gradient. We concluded that although triglycyllysine vasopressin significantly reduced portal pressure in patients with hepatitis B-related cirrhosis, it produced untoward systemic haemodynamic changes similar to those seen with vasopressin. The addition of nitroglycerin improved the detrimental systemic haemodynamic effects produced by triglycyllysine vasopressin without further reducing the hepatic venous pressure gradient.

AB - We measured the haemodynamic changes following triglycyllysine vasopressin administration and after addition of nitroglycerin in twelve patients with portal hypertension due to hepatitis B-related cirrhosis. A bolus i.v. injection of triglycyllysine vasopressin at a dose of 2 mg reduced the hepatic venous pressure gradient from 18.5 ± 3.7 (mean ± S.D.) to 15.6 ±4.0 mmHg, p < 0.001. However, the cardiac index decreased from 4.8 ± 1.0 to 3.7 ± 0.81/min m2, p < 0.001; the heart rate decreased from 79 ± 15 to 71 ± 13, p < 0.01; the right atrial pressure increased from 3.2 ± 1.9 to 5.3 ± 2.3 mmHg, p < 0.001; the mean arterial pressure increased from 92 ± 13 to 103 ± 13 mmHg, p < 0.05; and the systemic vascular resistance rose from 939 ± 182 to 1367 ± 310 dyn/s cm-5, p < 0.001. Furthermore, both mean pulmonary arterial pressure and pulmonary capillary wedge pressure showed a significant increase following triglycyllysine vasopressin administration as compared with baseline values (p < 0.005). The addition of sublingual nitroglycerin at a dose of 0.6 mg returned all the systemic haemodynamic parameters to baseline levels. On the other hand, nitroglycerin administration caused no further change in the hepatic venous pressure gradient. We concluded that although triglycyllysine vasopressin significantly reduced portal pressure in patients with hepatitis B-related cirrhosis, it produced untoward systemic haemodynamic changes similar to those seen with vasopressin. The addition of nitroglycerin improved the detrimental systemic haemodynamic effects produced by triglycyllysine vasopressin without further reducing the hepatic venous pressure gradient.

UR - http://www.scopus.com/inward/record.url?scp=0025343799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025343799&partnerID=8YFLogxK

U2 - 10.1016/0168-8278(90)90149-L

DO - 10.1016/0168-8278(90)90149-L

M3 - Article

VL - 10

SP - 370

EP - 374

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 3

ER -